Exosome RNA Exosome RNA Research & Industry News
Liquid biopsy is a new, minimally invasive technology for detection of disease biomarkers without the need for costly or invasive procedures. In this video, Dr. Brian Adams talks about the role of miRNA from exosomes as potential circulating biomarkers, challenges and recommended techniques for isolating these tiny microvesicles. Liquid biopsies promise to revolutionize the way serious diseases are detected and monitored.
Don't Miss
- Scientists explain regulation of extracellular vesicles by dephosphorylating Syntenin
- Overcoming Chemoresistance via Extracellular Vesicle Inhibition
- Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential
- Study focuses on a different kind of liquid biopsy to detect cancer
- Raman spectral signatures of serum-derived EVs may serve as liquid biopsy for diagnosis of CNS tumors
- Extracellular vesicles isolated from milk can improve gut barrier dysfunction induced by malnutrition
- Codiak presents data demonstrating potential of engineered exosomes
- Featured Exosome Job – Research Associate, College of Engineering and Applied Science
- Exosomes as new therapeutic vectors for pancreatic cancer treatment
- Monitoring durability of microRNA-based gene therapies in the central nervous system with extracellular vesicles
